IPO Calendar: 3 new issues, 12 listings to keep primary market busy next week (28-09-2024)
The next few months are going to be exciting for investors with some big companies likely to hit the public markets. These include, Hyundai Motor, Swiggy, Waaree Energies, NTPC Green, NSE among others.
B C C Fuba India Ltd: PCB Manufacturing Nanocap (28-09-2024)
Also as correctly pointed out by @rambaranwal, bare PCBs for each gadget, segment and industry is different and I believe B C C Fuba caters to all the most promising and flourishing sectors/spaces currently (including Automotive, power infrastructure, telecom, defense, medical, and railway). Moreover they cater to all the varied types of PCBs
As per their website,
And most importantly, they also have all the most important certifications (I could find for a PCB manufacturer),
Disc: Invested, very bullish therefore biased
Snowman Logistics (28-09-2024)
ChatGPT
You said:
Why is snow man logistics buying share
ChatGPT said:
ChatGPT
Searched 3 sites
Snowman Logistics is currently experiencing leadership changes, which is likely influencing its share activity. The company announced the resignation of CEO Sunil Prabhakaran Nair, effective November 2024, though he will remain a consultant afterward. This leadership shift might be prompting market interest or uncertainty, as Padamdeep Singh Handa will take over as CEO starting December 2024. Additionally, Snowman Logistics has been performing well recently, with its stock up by over 35% this year, driven by growth in the cold chain logistics sector, despite a dip in net profits in Q1 FY25(
MoneyControl
)(
MarketScreener
).
These factors—leadership changes and mixed financial results—could be leading to strategic share purchases in the company.
You said:
Give background of padamdeep
ChatGPT said:
ChatGPT
Padamdeep Singh Handa, who will become the CEO of Snowman Logistics on December 1, 2024, has extensive experience in the logistics and supply chain industry. He holds a Master’s in Business Administration and has over 15 years of professional experience. His expertise spans key areas such as cold chain logistics, exports, imports, transportation, and customs handling. Handa has been with Snowman Logistics for seven years, most recently serving as the Chief Commercial Officer, where he led the company’s sales, marketing, and operational functions(
MoneyControl
)(
MarketScreener
).
You said:
Past position in companies
ChatGPT said:
ChatGPT
Searched 4 sites
Padamdeep Singh Handa has extensive experience in leadership roles across various sectors. He is currently the Whole-Time Director and Chief Executive Officer (CEO) of Snowman Logistics, effective from December 1, 2024. Prior to this, he has held significant positions in several prominent companies. These include being a senior executive at Future Retail, where he worked in supply chain management and logistics. He also has a strong background in retail, warehousing, and distribution, which aligns well with his current role at Snowman Logistics.
His appointment follows his expertise in driving logistics and operational efficiency, particularly within industries requiring sophisticated supply chain management(
Whispersinthecorridors
)(
MarketScreener
).
Intresting artificial intelligence is progressing well but still lot more to learn
Bajel Projects wins first data centre order (28-09-2024)
Bajel Projects announced that it had successfully entered the emerging data centre segment by securing its first order from an upcoming data centre service provider.
Neuland Laboratories Limited – Transformation towards niche APIs? (28-09-2024)
Neuland has strong capabilities in biologics, particularly as a CDMO focused on peptides and oligonucleotides. Peptide synthesis, a core strength, is a growing market with an expected rise from $90.1 billion in 2023 to $157.5 billion by 2028. This growth is driven by increasing demand for peptide-based drugs, such as GLP-1 agonists, which are used in treatments for diabetes and weight management. Neuland’s biologics business aligns with this double-digit market growth (DCAT Value Chain Insights)
The biological CDMO space is highly competitive, with established players already dominating the market. Their focus on niche areas like peptides helps them carve out a specialized position, but scaling up and competing with larger global CDMOs will require continued investment and operational excellence (which I believe they have shown over and over again, i don’t think they have ever failed an FDA checking, either announced or unannounced, which no pharma company, I think has been able to achieve). So definitely, operational excellence I believe is unparalleled.
Disc: Invested
UBS initiates coverage on 6 pharma stocks. Sun Pharma, Cipla among top buys (28-09-2024)
The report points to weakening trends in both India and the US, with underappreciated growth slowdowns in these markets. UBS has provided a mixed outlook, issuing both ‘Buy’ and ‘Sell’ ratings on a range of pharmaceutical stocks.
Websol energy system ltd (28-09-2024)
Hi there.
This EPS is for cell manufacture only. The 550 MW module capacity has started in August. So it will add to the cell EPS and annualized EPS can be much higher than 25.16
thanks